Effect of Mutant Fibulin Expression on RPE Cell Function
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
M2006032
Goals
We hypothesize that the expression of mutant fibulin proteins compromises the ability of RPE cells to perform one of their primary functions, swallowing and processing of outer segments that are shed from photoreceptor cells. Evidence suggests that the rate of outer segment shedding and the ability of the RPE to remove and process the outer segments are key factors in the progression of AMD. The proposed studies would expand our understanding of these vital RPE functions and could point the way to AMD treatments that act by alleviating protein aggregation.
Grantee institution at the time of this grant: Pennsylvania State University
Summary
A single genetic mutation in the fibulin-3 gene causes inherited early-onset macular degenerative diseases known as Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD). Similar mutations in other fibulins (5 and 6) are linked to age-related macular degeneration (AMD). These mutations cause the expression of abnormal forms of fibulin proteins. How these abnormal proteins contribute to macular degeneration is unknown. We provide a testable hypothesis of how the expression of a mutant protein might cause retinal pigment epithelial (RPE) cell dysfunction, leading to macular degeneration. Expression of fibulin-3 mutant protein leads to the accumulation of this protein in an intracellular organelle called the endoplasmic reticulum (ER), causing stress to this organelle.
Grants
Related Grants
Macular Degeneration Research
Exosomes and Autophagy: Suspicious Partners in Drusen Biogenesis and AMD
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Miguel Flores Bellver, PhD
Exosomes and Autophagy: Suspicious Partners in Drusen Biogenesis and AMD
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Miguel Flores Bellver, PhD
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Maximilian Pfau, MD
Macular Degeneration Research
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Heike Kroeger, PhD